This year’s event builds on the phenomenal success of the 2018 re-launch of this highly respected competition – recognising and rewarding the most talented sales professionals working within the healthcare industry.
News
Iksuda signs licence agreement with Femtogenix for solid tumours
Iksuda Therapeutics and Femtogenix have signed a licensing agreement for antibody-drug conjugates.
Merck KGaA, Pfizer added to BioXcel’s pancreatic cancer deal
Merck KGaA and Pfizer have joined BioXcel and Nektar Therapeutics’ clinical collaboration to test Bavencio in combination with two other cancer therapies as a treatment for pancreatic cancer.
PHE launches ‘Cervical Screening Saves Lives’ campaign
A new cervical cancer screening campaign has been launched by Public Health England, as screenings fall to a 20-year low.
Major study again rejects that vaccinations cause autism
A new study has found “no increased risk for autism after MMR vaccination”.
BBC warns of illegal STI drugs being sold online
A BBC reporter has discovered an online trade of illegal drugs for STIs.
Verona announces positive results from Phase II COPD trial
Verona Pharma’s COPD inhaler has shown positive results in a Phase II study.
Study shows long-term efficacy for Ilumya in psoriasis
Sun Pharma’s Ilumya has proven to be efficient for up to three years of ongoing treatment.
Lynparza, Dupixent backed by CHMP for label extensions
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended extending the uses of AstraZeneca’s Lynparza and Sanofi’s Dupixent.
Syncona’s Nightstar Therapeutics to be bought by Biogen for $877 million
Nightstar Therapeutics has agreed to be acquired by Biogen.
EMA accepts marketing authorisation applications for Idefirix and Xospata
European regulators have accepted for review marketing authorisation applications for Hansa’s Idefirix and Astellas’ Xospata.
Eight medicines recommended in final London CHMP meeting
The first treatment for a rare disease characterised by high levels of triglycerides in blood is among eight new medicines put forward by the European Medicines Agency’a human medicines committee (CHMP) for approval.
Feraccru hits endpoints in anaemia trial
Oral iron replacement therapy Feraccru has been shown to have comparable efficacy to intravenously delivered Ferinject in patients with Iron Deficiency Anaemia, offering a “real” alternative to hospital administration for many patients.
Integrated NHS leadership team is ‘right move’
NHS Improvement and NHS England have shaken up their leadership team.
Napp launches pegfilgrastim biosimilar in the UK
Napp Pharmaceuticals has launched Pelmeg – a pegfilgrastim biosimilar – across the UK.
